Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07591480
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Interviews — OTHERParticipants will be offered a 30 to 45-minute telephone or video in-depth interview at a specific time convenient to the participants.
Study Details
The purpose of this research is to understand why some groups of people do not join clinical trials as much as others. These groups can include people from different racial or ethnic backgrounds, people with lower incomes, people who live in rural areas, and people who speak different languages. Investigators interview participants to learn about their experiences with clinical trials. By learning from them, investigators hope to find better ways to help more people learn about, join, and stay in clinical trials so that research is fair and helpful for everyone.
Key Dates
- Start date
- May 1, 2026
- Status verified
- May 2026
- Primary completion
- Oct 1, 2026
- Completion
- Oct 1, 2028
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: All patientsParticipants will be sampled using pre-selected demographic, geographic, and clinical characteristics, allowing for purposive sampling among patients with characteristics where disparities are known to exist.
Primary Outcome Measure
Questionnaires/Surveys [ Time Frame: Through study completion; an average of 1 year ]
Central Contacts
- Rebecca A Snyder, MD, MPH(713) 792-0036
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UT MD Anderson | Houston | Texas | 77030 | Rebecca A Snyder, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary CancerRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) RegistryRecruiting · University of Louisville · Birmingham, Alabama
- Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)Recruiting · M.D. Anderson Cancer Center · Los Angeles, California
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California